Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Gainers

  • Freight Technologies, Inc. (NASDAQ:FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
  • Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) shares jumped 114.9% to $20.20. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contingent value rights (CVRs) of up to $8.00 per share.
  • ToughBuilt Industries, Inc. (NASDAQ:TBLT) shares climbed 28.6% to $2.83 after the company reported better-than-expected Q3 EPS results.
  • Cosmos Holdings Inc. (NASDAQ:COSM) rose 27.7% to $0.1569 after gaining 7% on Friday.
  • Yiren Digital Ltd. (NYSE:YRD) jumped 27.7% to $1.29.
  • Exela Technologies, Inc. (NASDAQ:XELA) gained 25.8% to $0.35.
  • Ardelyx, Inc. (NASDAQ:ARDX) surged 25.6% to $1.5700. The FDA published briefing documents on Ardelyx's kidney disease treatment.
  • Ensysce Biosciences, Inc. (NASDAQ:ENSC) jumped 23% to $2.3700 after the company announced it received written guidance from the FDA that an acute pain indication may be appropriate for its lead Trypsin Activated Abuse Protection product, PF614.
  • CIRCOR International, Inc. (NYSE:CIR) surged 20.6% to $26.15 following better-than-expected quarterly results.
  • HireRight Holdings Corporation (NYSE:HRT) gained 19.1% to $9.18. HireRight’s board authorized a $100 million share repurchase program.
  • PDS Biotechnology Corporation (NASDAQ:PDSB) jumped 18.2% to $6.62 after the company announced 100% clinical response in cervical cancer patients in preliminary data from the IMMUNOCERV Phase 2 clinical trial. The company also reported better-than-expected Q3 EPS results.
  • Daseke, Inc. (NASDAQ:DSKE) gained 15.7% to $6.91. Daseke said that the company has entered into an agreement with its Founder, Mr. Don R. Daseke, and his affiliates, to repurchase their total holdings in the company at a purchase price of $6 per share.
  • HUTCHMED (China) Limited (NASDAQ:HCM) rose 15.3% to $11.41 after the company reported positive topline result in Fruquintinib Phase III FRUTIGA study in second-line gastric cancer in China.
  • Armata Pharmaceuticals, Inc. (NYSE:ARMP) jumped 14.6% to $3.29. Armata Pharmaceuticals recently reported a Q3 loss of $0.24 per share.
  • MINISO Group Holding Limited (NYSE:MNSO) gained 14.5% to $8.10 after the company reported better-than-expected Q1 financial results.
  • Helius Medical Technologies, Inc. (NASDAQ:HSDT) gained 14% to $0.2975 following strong quarterly results.
  • Agenus Inc. (NASDAQ:AGEN) rose 13.8% to $2.8550. Agenus recently posted a Q3 loss of $0.19 per share.
  • HUTCHMED (China) Limited (NASDAQ:HCM) surged 13.1% to $11.20 after the company reported initial results from FRUTIGA. The company said the trial met one of the primary endpoints of statistically significant improvement in progression-free survival.
  • Xinyuan Real Estate Co., Ltd. (NYSE:XIN) surged 12.6% to $0.5181.
  • Babcock & Wilcox Enterprises, Inc. (NYSE:BW) gained 10.4% to $5.38. Babcock & Wilcox Construction Co. LLC was awarded $42 million in large North American upgrade projects.
  • Secoo Holding Limited (NASDAQ:SECO) gained 10.3% to $0.32.
  • TAL Education Group (NYSE:TAL) gained 10.1% to $5.24.
  • Kidpik Corp. (NASDAQ:PIK) rose 10.1% to $0.9798. KIDPIK is expected to release Q3 results on November 15, 2022.
  • monday.com Ltd. (NASDAQ:MNDY) surged 9.2% to $103.94 after the company reported better-than-expected Q3 financial results.
  • Cabaletta Bio, Inc. (NASDAQ:CABA) gained 8.8% to $2.59. Cabaletta Bio recently posted a Q3 loss of $0.39 per share.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.